DCRI Accomplishments – Spring 2025

DCRI Accomplishments showcases the publications, awards, and other achievements of our faculty members. Each quarter, a new collection will highlight the most recent accomplishments.

Chris Lindsell Appointed to NCATS Advisory Council

Chris Lindsell

Chris Lindsell, PhD, was recently appointed to the National Center for Advancing Translational Sciences (NCATS) Advisory Council, effective through Oct. 31, 2028. Lindsell, director of the Data Science and Biostatistics department at the DCRI, has previously served as the president of the Association of Clinical and Translational Science, chaired the Translational Science conference, and currently serves as editor-in-chief of the Journal of Clinical and Translational Science.

Members of the NCATS Advisory Council provide guidance and recommendations to the Secretary of Health and Human Services, the NIH director, and the NCATS director on center initiatives, policies, and programs. Lindsell has been closely involved with NCATS in relation to his work with its Clinical and Transitional Science Awards program and has been a strong proponent of how biostatistics, informatics, and data science can advance clinical and translational science.

“As a member of the council, I hope to influence the quality and impact of clinical and translational science and to help prioritize innovation in the programs supported and led by NCATS,” Lindsell said of his appointment.

Laurie Sanders Selected as Scialog Fellow

Laurie Sanders

Laurie Sanders, PhD, was among 40 researchers selected as a fellow for the first meeting of Scialog: Neurobiology and Changing Ecosystems. The event is a Research Corporation for Science Advancement initiative, which aims to innovate new science that explores neurobiological responses to the challenges of rapid and extensive human-caused environmental changes. Since its inception in 2010, Scialog has supported early career faculty coming together as fellows to develop new research, foster dialogue, and form multidisciplinary teams to tackle major scientific challenges.

“It is an honor to have been chosen as one of Scialog’s Neurobiology and Changing Ecosystems Fellows,”Sanders said. “I am excited to work together with the other fellows to explore innovative and interdisciplinary research that addresses neurobiological responses caused by critical environmental changes.” 

The meeting, which is the first of three in this Scialog series, took place March 13-16 in Tucson, Arizona.

Daniel Gonzalez Wins Tanabe Young Investigator Award

Daniel Gonzalez

The American College of Clinical Pharmacology (ACCP) has selected Daniel Gonzales, PhD, as the recipient of their 2025 Tanabe Young Investigator Award. The annual award is funded by a grant from Tanabe Research Laboratories USA.

The Tanabe Young Investigator Award award recognizes the significant contributions of an investigator who has made unusual strides in clinical pharmacology research and whose career shows promise of outstanding achievements at a relatively early stage, typically 10-12 years post-research degree. Gonzalez, an Associate Professor in the Division of Clinical Pharmacology in the Duke School of Medicine’s Department of Medicine, will receive the award during the ACCP Annual Meeting, Sept. 14-16, in Phoenix, Arizona.

Susanna Naggie Awarded Distinguished Professorship  

Susanna Naggie

Susanna Naggie, MD, was among the 17 Duke University School of Medicine faculty members awarded a 2025 distinguished professorship by the Duke Board of Trustees. Distinguished professorships are awarded to faculty who “have demonstrated extraordinary scholarship in advancing science and improving human health.” The 2025 distinguished professorships will take effect on July 1, 2025, or thereafter.  

Naggie is a professor of medicine and a clinical investigator focused on clinical trials in infectious diseases and translational research in HIV and liver disease. She was selected as the Catherine Wilfert Distinguished Professor of Medicine, which acknowledges her work on clinical initiatives that aim to introduce new antiviral agents to patients, as well as her focus on infectious diseases and translational research in HIV and liver disease. Duke University will recognize Naggie alongside other distinguished professors at their annual celebratory event on May 14. 

Share